Subjects: H.R.3334 — 110th Congress (2007-2008)

  • Child health
  • Clinical trials
  • Congress
  • Congressional reporting requirements
  • Drug therapy
  • Epidemiology
  • Families
  • Health
  • Hereditary diseases
  • Medical research
  • Muscular diseases
  • Orphan drugs
  • Pharmaceutical research
  • Science, Technology, Communications